In addition, there were positive relationships among expression levels of the A20, CYLD and Cezanne genes (Table 4), and the expression levels of CYLD did not affect clinical features and immunophenotypes in B-ALL patients. This evidence concerns the gene CYLD and acute lymphoblastic leukemia.